Double-blind, Randomized, Placebo-controlled Study on Efficacy, Safety and Tolerability of Ancrod in Patients With Sudden Sensorineural Hearing Loss (SSHL)
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Ancrod (Primary) ; Ancrod (Primary)
- Indications Sensorineural hearing loss; Sudden hearing loss
- Focus Therapeutic Use
- Sponsors Nordmark Arzneimittel
- 15 Jun 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 15 Jun 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
- 15 Jun 2017 Status changed from recruiting to active, no longer recruiting.